1040.20 -3.90 (-0.37%)

Near 52W Low of ₹1010.00

435.0K NSE+BSE Volume

NSE 08 Sep, 2025 3:31 PM (IST)

US FDA Observation
Aurobindo Pharma gets Form 483 with eight observations from the US FDA for its Telangana facility See details


Aurobindo Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AUROPHARMA, BSE:524804 Aurobindo Pharma Ltd.

1256 Votes:
Buy 80.25%
Sell 13.77%
Hold 5.97%
BUY
SELL
HOLD